Detalhe da pesquisa
1.
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.
J Eur Acad Dermatol Venereol
; 38(1): e102-e105, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611255